Alamar Biosciences, Inc. (ALMR)
Q2 2026Earnings receipt·reported Aug 10, 2026 · After Close·quarter ended Jun 30, 2026
The street expected
EPS consensus
-$0.36
3 analysts · street range -$0.40 – -$0.30
Year-ago EPS
N/A
same basis as the consensus row
frozen Aug 10, 2026 — before the print erased it
The company printed
EPS (GAAP)
($0.22)
Revenue
$29.4M
verified from the wire release · figures published 4:06 PM ET
Consensus into the print
The bar held at -$0.36 across 3 nightly snapshots into the print.
Aug 8, 2026Aug 10, 2026
Why this page exists
Every public surface destroys the “expected” number at the moment it matters: the actual overwrites it, and post-hoc surprise figures get computed against restated consensus. This receipt was frozen from Wall St Engine’s nightly expectation archive before the print and joined to figures verified from the release itself. It does not update, and it cannot be reconstructed after the fact.
receipt frozen 2026-08-10 20:06 UTC · actuals last refined 2026-08-13 03:55 UTC · ALMR company page